skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Covid-19: Drug companies urged to share vaccine technology to boost equity and access

BMJ (Online), 2022-04, Vol.377, p.o1086-o1086 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for personal use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.o1086 ;PMID: 35483726

Full text available

Citations Cited by
  • Title:
    Covid-19: Drug companies urged to share vaccine technology to boost equity and access
  • Author: Wise, Jacqui
  • Subjects: Coronaviruses ; COVID-19 - prevention & control ; COVID-19 vaccines ; Humans ; Manufacturers ; mRNA vaccines ; News ; Pandemics ; Public health ; Stockholders ; Technology ; Technology transfer ; Vaccines
  • Is Part Of: BMJ (Online), 2022-04, Vol.377, p.o1086-o1086
  • Description: Campaigners including the head of the World Health Organization have urged pharmaceutical companies to share technology and knowledge in order to improve covid-19 vaccine equity and access. WHO director general Tedros Adhanom Ghebreyesus and representatives from the People’s Vaccine Alliance are presenting shareholder resolutions on behalf of Oxfam at the annual general meetings of Moderna, Pfizer, and Johnson & Johnson.123 Abby Maxman, president of Oxfam America, said, “Moderna, Pfizer, and Johnson & Johnson have prioritised short term profit making over long term sustainability and reputational risks, as well as public health needs. Speaking to Moderna shareholders in a pre-recorded statement, Tedros said, “If Moderna worked with us, we could submit the technology transfer hub’s vaccine for approval at least one year sooner, which would save lives, decrease the risk of variants, and reduce the pandemic’s economic toll.
  • Publisher: England: British Medical Journal Publishing Group
  • Language: English
  • Identifier: ISSN: 1756-1833
    EISSN: 1756-1833
    DOI: 10.1136/bmj.o1086
    PMID: 35483726
  • Source: AUTh Library subscriptions: ProQuest Central
    MEDLINE
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait